Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
AIDS Res Hum Retroviruses ; 20(3): 315-25, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15117455

ABSTRACT

Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune responses that are effective in regions of the world where non-clade B viruses predominate. To address these issues we isolated CD4(+) T cell clones from individuals with vigorous HIV-1-specific Th cell responses and identified the minimum epitopes recognized. The minimum peptide length required for induction of CD4(+) T cell proliferation, IFN-gamma secretion, and cytolytic activity ranged from 9 to 16 amino acids in the five epitopes studied. Cross-clade recognition of the defined epitopes was examined for variant peptides from clades A, B, C, D, and AE. Over half the variant epitopes (17 of 32) exhibited impaired recognition, defined as less than 50% of the IFN-gamma secretion elicited by B clade consensus sequence. There was no evidence for antagonistic activity mediated by the variant peptides, and despite strong responses there was no escape of autologous virus from Th responses in the epitopes we studied. Abrogated recognition of variant CD4(+) T cell epitopes presents a potential obstacle to vaccine development.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Epitope Mapping , Epitopes, T-Lymphocyte/immunology , HIV Core Protein p24/immunology , HIV-1/immunology , Amino Acid Sequence , Clone Cells , Cross Reactions , Epitopes, T-Lymphocyte/chemistry , HIV Core Protein p24/chemistry , HIV Core Protein p24/genetics , HIV Infections/immunology , HIV Infections/virology , HIV-1/chemistry , HIV-1/genetics , Humans , Interferon-gamma/metabolism , Lymphocyte Activation , Molecular Sequence Data , Peptides/chemistry , Peptides/pharmacology
2.
Blood ; 107(6): 2373-83, 2006 Mar 15.
Article in English | MEDLINE | ID: mdl-16322475

ABSTRACT

T-cell receptor (TCR) diversity of virus-specific CD8+ T cells likely helps prevent escape mutations in chronic viral infections. To understand the dynamics of the virus-specific T cells in more detail, we followed the evolution of the TCR repertoire specific for a dominant HLA-B*08-restricted epitope in Nef (FLKEKGGL) in a cohort of subjects infected with HIV. Epitope-specific CD8+ T cells used structurally diverse TCR repertoires, with different TCRbeta variable regions and with high amino acid diversity within antigen recognition sites. In a longitudinal study, distinct Vbeta populations within the HIV-specific TCR repertoire expanded simultaneously with changes in plasma viremia, whereas other Vbeta populations remained stable or even decreased. Despite antigenic variation in some subjects, all subjects had the consensus sequence present during the study period. Functional analysis of distinct Vbeta populations revealed differences in HIV-specific IFN-gamma secretion ex vivo as well as differences in tetramer binding, indicating functional heterogeneity among these populations. This contrasts with findings in a subject on antiretroviral therapy with suppression of viremia to less than 50 copies/mL, where we observed long-term persistence of a single clonotype. Our findings illustrate the flexibility of a heterogeneous HIV-1-specific CD8+ TCR repertoire in subjects with partial control of viremia.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , HIV/immunology , Receptors, Antigen, T-Cell/immunology , T-Cell Antigen Receptor Specificity , Adult , Aged , Antigenic Variation , CD8-Positive T-Lymphocytes/virology , Clone Cells/immunology , Cohort Studies , Consensus Sequence , HIV Infections/immunology , Humans , Immunodominant Epitopes , Interferon-gamma/metabolism , Longitudinal Studies , Middle Aged , Viremia/prevention & control
3.
J Virol ; 79(13): 8171-81, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15956562

ABSTRACT

Studies in acute human immunodeficiency virus type 1 (HIV-1) infection indicate viral evolution under CD8 T-cell immune selection pressure, but the effects of ongoing immune pressure on epitope evolution during chronic infection are not well described. In this study, we performed a detailed longitudinal analysis of viral sequence variation within persistently targeted cytotoxic T-lymphocyte (CTL) epitopes in two HIV-1-infected persons during 6 years of persistent viremia. Responses were quantitated using freshly isolated peripheral blood lymphocytes in direct lytic assays as well as by gamma interferon (IFN-gamma) Elispot assays on cryopreserved cells. Seven targeted epitopes were identified in each person. In the majority of cases, the dominant epitope sequence did not change over time, even in the presence of responses of sufficient magnitude that they were detectable using fresh peripheral blood mononuclear cells in direct lytic assays. Only 4 of the 14 autologous epitopes tested represented potential CTL escape variants; however, in most cases strong responses to these epitopes persisted for the 6 years of study. Although persistent IFN-gamma responses were detected to all epitopes, direct lytic assays demonstrated declining responses to some epitopes despite the persistence of the targeted sequence in vivo. These data indicate limited viral evolution within persistently targeted CD8 T-cell epitopes during the chronic phase of infection and suggest that these regions of the virus are either refractory to sequence change or that persistently activated CD8 T-cell responses in chronic infection exert little functional selection pressure.


Subject(s)
Acquired Immunodeficiency Syndrome/immunology , CD8-Positive T-Lymphocytes/immunology , Evolution, Molecular , HIV-1/genetics , Amino Acid Sequence , Base Sequence , CD4 Lymphocyte Count , CD8-Positive T-Lymphocytes/virology , DNA Primers , Epitopes/analysis , Epitopes/genetics , Genetic Variation , Humans , Longitudinal Studies , Polymerase Chain Reaction , T-Lymphocytes, Cytotoxic/immunology , Viral Load
4.
J Virol ; 79(21): 13239-49, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16227247

ABSTRACT

The sequence diversity of human immunodeficiency virus type 1 (HIV-1) represents a major obstacle to the development of an effective vaccine, yet the forces impacting the evolution of this pathogen remain unclear. To address this issue we assessed the relationship between genome-wide viral evolution and adaptive CD8+ T-cell responses in four clade B virus-infected patients studied longitudinally for as long as 5 years after acute infection. Of the 98 amino acid mutations identified in nonenvelope antigens, 53% were associated with detectable CD8+ T-cell responses, indicative of positive selective immune pressures. An additional 18% of amino acid mutations represented substitutions toward common clade B consensus sequence residues, nine of which were strongly associated with HLA class I alleles not expressed by the subjects and thus indicative of reversions of transmitted CD8 escape mutations. Thus, nearly two-thirds of all mutations were attributable to CD8+ T-cell selective pressures. A closer examination of CD8 escape mutations in additional persons with chronic disease indicated that not only did immune pressures frequently result in selection of identical amino acid substitutions in mutating epitopes, but mutating residues also correlated with highly polymorphic sites in both clade B and C viruses. These data indicate a dominant role for cellular immune selective pressures in driving both individual and global HIV-1 evolution. The stereotypic nature of acquired mutations provides support for biochemical constraints limiting HIV-1 evolution and for the impact of CD8 escape mutations on viral fitness.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Evolution, Molecular , HIV Infections/immunology , HIV-1/genetics , HIV-1/immunology , Mutation/immunology , Polymorphism, Genetic , Selection, Genetic , Acute Disease , Alleles , Amino Acid Sequence , Amino Acid Substitution , Chronic Disease , Cohort Studies , Epitopes, T-Lymphocyte/genetics , Genes, MHC Class I/genetics , Germany , HIV Infections/virology , Humans , Lymphocyte Count , Molecular Sequence Data , Sequence Alignment , United States
5.
J Virol ; 78(13): 7069-78, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15194783

ABSTRACT

Numerous studies now support that human immunodeficiency virus type 1 (HIV-1) evolution is influenced by immune selection pressure, with population studies showing an association between specific HLA alleles and mutations within defined cytotoxic T-lymphocyte epitopes. Here we combine sequence data and functional studies of CD8 T-cell responses to demonstrate that allele-specific immune pressures also select for mutations flanking CD8 epitopes that impair antigen processing. In persons expressing HLA-A3, we demonstrate consistent selection for a mutation in a C-terminal flanking residue of the normally immunodominant Gag KK9 epitope that prevents its processing and presentation, resulting in a rapid decline in the CD8 T-cell response. This single amino acid substitution also lies within a second HLA-A3-restricted epitope, with the mutation directly impairing recognition by CD8 T cells. Transmission of the mutation to subjects expressing HLA-A3 was shown to prevent the induction of normally immunodominant acute-phase responses to both epitopes. However, subsequent in vivo reversion of the mutation was coincident with delayed induction of new CD8 T-cell responses to both epitopes. These data demonstrate that mutations within the flanking region of an HIV-1 epitope can impair recognition by an established CD8 T-cell response and that transmission of these mutations alters the acute-phase CD8(+) T-cell response. Moreover, reversion of these mutations in the absence of the original immune pressure reveals the potential plasticity of immunologically selected evolutionary changes.


Subject(s)
Amino Acid Substitution , Antigen Presentation , Evolution, Molecular , Gene Products, gag/genetics , HIV Antigens/genetics , HIV-1/immunology , T-Lymphocytes, Cytotoxic/immunology , Viral Proteins/genetics , Amino Acid Sequence , Epitopes, T-Lymphocyte/immunology , HIV Infections/immunology , HIV Infections/virology , HIV-1/genetics , HLA-A3 Antigen/metabolism , Humans , Immunodominant Epitopes/immunology , Molecular Sequence Data , Selection, Genetic , gag Gene Products, Human Immunodeficiency Virus
SELECTION OF CITATIONS
SEARCH DETAIL